Interesting and important material here. Credit to Diggie's Friend.
Pairing (Quercetin Liposomal) in concert with Amoxicillin was found to lessen inhibit negative side effect damage to the the liver and the kidneys and kidney function.[COLOR=#333333][FONT=Tahoma][I]
LY-poh-SOH-mul) A drug preparation that contains the active drug inside very tiny, fat-like particles. This form is easier for the body to absorb and allows more drug to get to the target area of the body, such as a tumor.
QR-lipo was developed and successfully employed to mitigate (lower) antibiotic-induced liver
injury . QR-lipo (Quercetin Liposomal)pretreatment activated the SIRT1/Nrf2/NF-κB signaling pathway to improve antioxidant and anti-inflammatory effects in Co-Amox-treated rats. Furthermore, QR-lipo inhibited antibiotic-induced microbiota dysbiosis (destruction)[/B]. The study suggested that QR-lipo might ameliorate Co-Amox-induced hepatic insults through multifactorial protective pathways
Dysbiosis of the gut
Gut dysbiosis is an imbalance in the gut microbiome, characterized by a loss of beneficial bacteria, an overgrowth of harmful bacteria, and a reduction in bacterial diversity...
The big news for using Quercetin Liposomal with Amoxicillin, is that it increased its ability to counter bad forms of bacteria, and inhibited the damage that this AB at higher doses in rats has been found to do.
Published research shows that liposomal quercetin significantly reduces liver and kidney damage induced by amoxicillin/clavulanate (Co-Amox) in rats. While amoxicillin alone can cause renal damage, the liposomal quercetin formulation boosts the protective effects against both liver and kidney injury by increasing antioxidant activity and modulating the inflammatory response.
Amoxicillin-induced kidney and liver toxicity in rats
Studies have confirmed that amoxicillin, particularly when combined with clavulanate as Co-Amox, can cause adverse effects on the liver and kidneys of rats. This damage is driven by an increase in oxidative stress, which leads to inflammation and cellular harm in these organs.
A 2018 study found that amoxicillin treatment in rats led to significantly higher levels of serum creatinine and urea, key indicators of kidney damage.
How liposomal quercetin reduces organ damage
Quercetin, a natural flavonoid, has well-documented antioxidant and anti-inflammatory properties, but its poor bioavailability limits its effectiveness. Creating a liposomal formulation addresses this issue by improving its solubility and delivery to target tissues.
Targeting oxidative stress: Quercetin liposomes (QR-lipo) have been shown to increase the antioxidant capacity of the liver, protecting it from damage caused by Co-Amox. A 2023 study found that QR-lipo significantly increased the expression of antioxidant transcription factors such as Nrf2.
Modulating inflammatory pathways: The same 2023 study found that QR-lipo downregulated key pro-inflammatory markers (IL-6, IL-1β, and TNF-α) and upregulated the anti-inflammatory marker IL-10, helping to mitigate the damaging inflammatory response triggered by Co-Amox.
Gut microbiome modulation: The study also noted that QR-lipo helped prevent Co-Amox-induced gut dysbiosis by promoting the growth of beneficial gut bacteria.
Synergistic effects of amoxicillin and quercetin against bacteria.
In addition to its protective effects against drug toxicity, research has also demonstrated a synergistic effect between amoxicillin and quercetin in fighting antibiotic-resistant bacteria. Quercetin has been shown to increase the permeability of bacterial cell membranes and inhibit β-lactamase, an enzyme that allows bacteria to resist amoxicillin.
There are though conditions where infection it so great, that Amoxicillin with' Quercetin Liposomal' (no bromalin), that had significant benefits; including reducing it's negative impact to the liver for one while increasing this Amoxicillin's effectiveness.
In a particular resistant form of Staph infection that is Amoxicillin resistant, when adding (QUER-Lipo) it eliminated the resistance of the resistant Staph species to Amoxicillin.



Reply With Quote
